REFEREE REPORTS
Referee #1:
This manuscript by Patriarch et al. is an important and excellently-performed study that sheds light on the mechanism of desensitization of beta-adrenergic modulation of CaV1.2 (L-type) ion channels in brain. The authors use a combination of approaches, centrally immunochemistry and biochemical, but also single-channel recording from hippocampal neurons, optical fluorescent imaging and measurements of synaptic plasticity between hippocampal regions that are known to depend upon adrenergic tone. Overall, this is a very strong manuscript that after minor revisions should make a strong contribution to EMBO J., as detailed below:
1. The hippocampus contains a diverse collection of both primary neuronal types (pyramidal CA1, CA2, CA3, DG granule cells) and interneurons. In the patch-clamp experiments shown in Fig. 7 , it is critical to know which type of neuron was patched. Although this is not my specialty, I am told by numerous experts who do such experiments that it is very easy after a short time to distinguish which types of neuron is being patched, based on i) morphology, ii) input resistance at negative potentials (e.g., DGG cells have extremely high input resistance), iii) spontaneous firing at I=0 in CC mode, which should have been done before commencing voltage-clamp.
2. In general, the measurements of distance between BARs and LTCCs in the fluorescence experiments on cultured hippocampal neurons (again, which type? we don't know)are weak (Fig. 4) . The resolution seems very low, and I am astonished that the difference in distance in the pooled data shown in Fig. 4C is statistically significant, given the small difference in the mean, and the very large error bars. Are the authors sure of this? In addition, there is no description of the methods used for such imaging, either in the main text nor in the appendix. We need to know i) if these are confocal images, and ii) what machine was used, the details of the optics, objectives, the pointspread function, etc. These data as they are, are unconvincing.
3. I cannot figure out the PTT-LTP experiments, and what the data mean in Fig. 9 . At first after the tetanus, the fESPC plunges in panels A,B,G,H, before becoming enhanced in the appropriate experiment. Why is the "plunge" only seen upon 5 Hz stimulation, but not 100 Hz? Please guide the reader through the expectations of these experiments, in case they are not particular experts in PTT-LTP (as opposed to LTP).
Referee #2:
This manuscript by Patriarchi et al. presents a number of important new findings regarding regulation of both GPCR-cAMP second messenger and Ca2+ channel signaling. In particular, the authors characterize in exquisite detail a completely novel negative feedback mechanism that limits enhancement of Cav1.2 L-type voltage-gated Ca2+ channel after activation of Beta2-adrenerigic receptors (B2AR)-cAMP-PKA signaling in neurons. The many exciting new discoveries in the study are as follows:
1) The B2AR C-terminal domain and the Cav1.2 C-terminal domain directly interact through a small region in the Cav1.2 C-terminus surrounding S1928, a major site of PKA phosphorylation.
2) This interaction between the B2AR and Cav1.2 is required for activation of B2AR's to enhance Cav1.2 currents and promote B2AR and Cav1.2-dependent induction of LTP in response to prolonged theta-train stimulation (PTT-LTP).
3) The demonstration of a requirement of Cav1.2 L-channels in B2AR-dependent PTT-LTP is itself an important new discovery. 4) PKA-phosphorylation of S1928 in the Cav1.2 C-terminus after B2AR activation leads to disruption of the Cav1.2-B2AR interaction to transiently uncouple the channel from B2AR-cAMP-PKA regulation of channel phosphorylation, both on S1928 and on S1700 (a PKA site implicated in enhancement of L-channel activity), and also prevents additional enhancement of L-channel function. 5) At the same time, B2AR association with and regulation of PKA phosphorylation of GluA1-AMPA receptors is completely unaffected. Thus, this novel B2AR-PKA negative feedback mechanism, unlike other previously characterized B2AR negative feedback mechanisms (GRK phosphorylation, arrestin binding, receptor internalization, Gs to Gi switching), is substrate-specific for L-channels. 6) S1928 has long been known to be the major site of PKA phosphorylation in Cav1.2, but recent studies have demonstrated that this site plays little or no role in B2AR-mediated enhancement of channel activity, raising many questions of what exactly is the function of this very prominent PKA phosphorylation site. Thus, discovery of a role for S1928 phosphorylation in negative feedback regulation of B2AR signaling helps solve a major mystery in the field.
The study is also extremely well executed and uses a powerful combination of biochemistry, fluorescence imaging, single channel recording, and extracellular field recording. The data are for the most part very clear and convincing. I only have a few minor issues that need to be addressed: a) In figure 4 , the immunostaining data showing decreased co-localization of Cav1.2 and B2AR after Iso stimulation of hippocampal neurons could benefit from some additional, independent analyses of co-localization such as using more standard Pearson's correlation analysis and/or calculation of integrated intensity co-localization ratios measuring the relative overlap of B2AR and Cav1.2 puncta. The measurements of changes in the distance between the centers of intensity of B2AR and Cav1.2 puncta before and after Iso stimulation are only 0.24 and 0.34 microns, respectively. These values are right at the edge of the diffraction-limited resolution of standard confocal microscopy. Thus, short of doing super-resolution, such as SIM STED, and STORM, I think the authors should confirm this finding using one or both of the above-mentioned intensity based co-localization methods to analyze their imaging data. Also, confidence would be higher if the authors could demonstrate that the B2AR and Cav1.2 co-localization is restored after Iso washout at time points when they see re-association in their IP experiments (i.e. 20 min). Thank you for submitting your revised manuscript. It has now been re-reviewed by the referees. As you can see below, both referees appreciate the introduced changes and support publication here. I am therefore very pleased to accept the manuscript.
There are just a few technical things to sort out -There is very little materials and method provided in the manuscript. It is OK to have some in the appendix, but the main part should be in the main file. Can you reshuffle -we have no limits on character count.
-Supplementary tables are not referenced in manuscript. They should be called Appendix Table S1 , etc.
- The authors have addressed all the concerns of the reviewers. It should be published in EMBO J. promptly.
Referee #2:
The authors have done an excellent job of responding to the prior review. I recommend publication of this very interesting and well done study without further delay. We are all delighted to hear the latest good news that our manuscript has been accepted for publication in EMBO J. At the same time we understand that we need to make some editorial changes, which we did as follows. 
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation. a statement of how many times the experiment shown was independently replicated in the laboratory.
Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
Please ensure that the answers to the following questions are reported in the manuscript itself. We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects.
In the pink boxes below, provide the page number(s) of the manuscript draft or figure legend(s) where the information can be located. Every question should be answered. If the question is not relevant to your research, please write NA (non applicable).
B--Statistics and general methods
the assay(s) and method(s) used to carry out the reported observations and measurements an explicit mention of the biological and chemical entity(ies) that are being measured. an explicit mention of the biological and chemical entity(ies) that are altered/varied/perturbed in a controlled manner. the exact sample size (n) for each experimental group/condition, given as a number, not a range; a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.).
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified
YOU MUST COMPLETE ALL CELLS WITH A PINK BACKGROUND 
The sample size for our biochemical, electrophysiological wand immunofluorescence analyses was deemed adequate based on previously published work.
17. For tumor marker prognostic studies, we recommend that you follow the REMARK reporting guidelines (see link list at top right). See author guidelines, under 'Reporting Guidelines'. Please confirm you have followed these guidelines. see table 1   not applicable In this study, wild type and S1928A KI mice were used. The generation of S1928A KI mice is detailed in (Lemke et al., 2008, as cited) . Both female and male mice of approximately 3--5 weeks of age were utilized for both the biochemical and electrophysiological experiments. Both wild type and S1928A KI animals were housed in the Animal Care Unit in Tupper Hall at UC Davis. This facility is fully approved for NIH--funded research. It is AAALAC accredited and maintains various laboratory animals including rats and mice in a highly controlled environment. This environment is optimized for the comfort of rodents and is in accordance with the applicable portions of the Animal Welfare Act and the DHS "Guide to the Care and Use of Animals". Its OLAW Assurance number is A3433--01. Males and Females were housed in separate cages, except when setting up breeding pairs. A maximum number of 4 animals was allowed per cage. Teaching Research and Animal Care Services (TRACS) husbandry staff was responsible for the feeding, watering and care of the animals 365 days a year. They are involved in the receipt of animals, cage/animal identification and animal transport. All animal procedures followed NIH guidelines and were approved by the UC Davis IACUC. 
